Mohan Rao, Expression Therapeutics CEO

Cincin­nati plays host to new cell, vi­ral vec­tor man­u­fac­tur­ing site from Ex­pres­sion Ther­a­peu­tics

Ex­pres­sion Ther­a­peu­tics’ new cell and vi­ral vec­tor man­u­fac­tur­ing site is up and run­ning in Cincin­nati.

The 43,000 square-foot site will pro­vide end-to-end R&D ca­pa­bil­i­ties and both ear­ly phase- and com­mer­cial-scale man­u­fac­tur­ing of lentivi­ral and ade­no-as­so­ci­at­ed vi­ral vec­tors. The site will have a mix of 30-180 liter runs in cell stacks and up to 1,000 liter runs in biore­ac­tors, with the ca­pa­bil­i­ty to man­u­fac­ture up to 100 prod­ucts per year. It al­so gives the nec­es­sary in­fra­struc­ture to ful­fill its ex vi­vo cell pro­cess­ing, and re­com­bi­nant pro­tein pro­duc­tion needs.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.